Merger and Acquisition Antitrust Review, Case Examples, and Enterprise Practice
Antitrust scrutiny complicates large enterprise mergers and acquisitions, stretches approval timelines, and often prompts companies to use divestitures or joint ventures to address regulatory concerns. According to Boston Consulting Group's January 15, 2026 M&A Outlook, global M&A value rose 31% in 2025 to $3.0 trillion across about 33,000 majority deals, including 39 megadeals valued above $10 billion. Enterprise deal teams prepare for this environment by setting clear financial guardrails, prepackaging carve-outs, and using AI tools for contract redaction and due diligence.
Updated
How antitrust review and regulatory rules shape enterprise M&A
When you get an M&A case in your consulting or banking interview, you cannot stop at standalone valuation and cost synergies. Traditional antitrust regulations complicate larger deals, make approval outcomes harder to predict, and lengthen timelines to close. According to Boston Consulting Group's October 16, 2024 M&A Report, heightened antitrust scrutiny and evolving regulatory rules are of special concern to large technology and pharmaceutical companies as they grow. If your interview is coming up soon, you can Practice a case free, no sign-up to test how regulatory limits change a deal recommendation.
In your case structure, remember that antitrust review does not only block transactions. In some cases, antitrust scrutiny promotes dealmaking because companies use divestitures and carve-outs to resolve regulatory concerns and clear the main transaction. You can also propose collaborative structures, such as joint ventures and partnerships, when your client needs to share investment, technology, and regulatory risk rather than buy a competitor outright.
When an interviewer asks you what risks could delay or derail a cross-border acquisition, walk through these overlapping regulatory layers whose impact varies by country:
- Traditional antitrust and competition review, which tests market consolidation and often requires divestitures to clear larger deals.
- Foreign direct investment restrictions, national security considerations, and international sanctions policies, which add friction and extend deal timelines.
- Data and privacy protection laws alongside cybersecurity issues, which receive heightened scrutiny during the M&A review process.
- Environmental, social, and governance standards and climate change regulations, which shape how companies evaluate and structure transactions before they execute them.
Enterprise M&A and consolidation case examples (2024 and 2025)
Knowing the real deal numbers helps you reality-check your math and sound informed when an interviewer asks about recent market trends. For the full year, global M&A deal value reached $3.0 trillion in 2025, an increase of 31% compared with the previous year and slightly above the ten-year average of roughly $2.9 trillion. Total deal volume stayed broadly stable at about 33,000 majority M&A deals in 2025, compared with about 33,800 in 2024 and a record high of about 41,300 in 2021. By our calculation from the 2025 deal totals, the average value across the roughly 33,000 majority deals in 2025 was about $90.9 million per transaction ($3.0 trillion divided by 33,000 deals).
If your case involves a multibillion-dollar corporate buyer, you are looking at the segment that drove the 2025 rebound. Dealmakers announced about 900 large deals valued at or above $500 million in 2025, exceeding the 2024 total by more than 100, and monthly activity settled into the typical global range of roughly 60 to 80 large deals per month. Megadeals valued at more than $10 billion rose to 39 announced transactions in 2025, up from 28 in 2024, though still below the record 51 in 2021. By our calculation from the megadeal totals, megadeal announcements increased by 39.3% from 2024 to 2025 (11 additional megadeals divided by 28).
You should also pay attention to where deals happen when you scope a geographic expansion case. Targets in North America accounted for $1.9 trillion of 2025 deal value (up about 58% from 2024), with US targets representing $1.8 trillion, or 60% of global M&A activity. European M&A totaled $524 billion (down 1%), Asia-Pacific reached $440 billion (down 3%), South and Central America totaled $73 billion (up 25%), the Middle East reached $21 billion (up 3%), and Africa totaled $12 billion (down 14%). In the first nine months of 2024, global deal value had risen 10% to $1.6 trillion across about 22,400 transactions, with 17 megadeals reported compared with 28 and 20 in the same period of 2022 and 2023. You can use the 2024 and 2025 transaction examples in the table below as concrete illustrations when you discuss deal rationale or regulatory remedies in your interviews.
Selected 2024 and 2025 enterprise M&A and joint venture examples from BCG M&A reports
| Parties | Sector and region | Reported value | Deal structure and strategic or regulatory context |
|---|---|---|---|
| The Walt Disney Co. and Reliance Industries | Media and entertainment (India) | $8.5 billion | Received conditional regulatory approval in 2024 to merge Indian media assets into a joint venture creating India's largest entertainment company. |
| Paramount Skydance / Netflix and Warner Bros. Discovery | TMT (US) | $74.3 billion vs. $69.9 billion | Rival late-2025 offers for Warner Bros. Discovery, with Paramount Skydance tendering $74.3 billion to surpass Netflix's $69.9 billion offer. |
| Union Pacific and Norfolk Southern | Transportation and rail (US) | $71.5 billion | 2025 acquisition announcement marking a major consolidation in US freight transportation. |
| Silver Lake, Saudi Arabia PIF, Affinity Partners, and Electronic Arts | TMT / Gaming (Global) | About $49.4 billion | 2025 consortium acquisition. If completed, the largest leveraged buyout ever before inflation adjustment. |
| Kimberly-Clark and Kenvue | Consumer health (US) | $42.8 billion | 2025 intended acquisition of consumer health products maker Kenvue. |
| AI Infrastructure Partnership, Global Infrastructure Partners, MGX, and Aligned Data Centers | TMT / Data centers (US) | $40.0 billion | 2025 investor group acquisition of data processing and hosting-services provider. |
| Alimentation Couche-Tard and Seven & i Holdings | Consumer retail (Canada / Japan) | $38.7 billion | 2024 intended cross-border acquisition in the consumer sector. |
| Alphabet and Wiz | Technology / Cloud security (US) | $32.0 billion | 2025 corporate acquisition to pursue strategic growth in cloud security software. |
| Mars Inc. and Kellanova | Consumer staples (US) | $29.7 billion | 2024 bid in the US consumer sector. Combined with Seven & i, accounted for $68.4 billion in proposed consumer deals. |
| Constellation Energy and Calpine | Energy and utilities (US) | $26.9 billion | 2025 acquisition by electric utility Constellation Energy to expand power generation footprint. |
| Palo Alto Networks and CyberArk | Technology / Cybersecurity (US) | $25.1 billion | 2025 acquisition intended to create an end-to-end security platform for AI. |
| Volkswagen and Rivian | Automotive / EV (Germany / US) | Up to $5.0 billion | 2024 joint venture investment to develop and share EV architecture and software. |
| KKR, T-Mobile US, and Metronet Holdings | Telecommunications (US) | $4.9 billion | 2024 collaborative acquisition of subscription programming services provider. |
| BHP, Lundin Mining, and Filo | Materials / Mining (Canada) | $3.2 billion | 2024 50-50 joint venture and acquisition to advance the Filo del Sol and Josemaria copper projects. |
Sector consolidation examples in banking, health care, and technology
When you Tailor your case structure to a specific industry, remember that regulatory complexity and consolidation pressure differ sharply across sectors. In 2025, aggregate deal value rose 91% in the industrial sector, 68% in health care, 49% in technology, media, and telecommunications, 33% in energy and utilities, and 7% in financial services and real estate, while falling 7% in the consumer sector (where retail M&A dropped 29%, consumer staples rose 9%, and products and services rose 3%) and falling 7% in materials.
If you draw a health care or pharmaceutical case, note that incumbents consistently seek targets to refresh pipelines and expand portfolios despite heightened antitrust attention on large pharma companies. For example, Pfizer acquired obesity drug developer Metsera in a transaction that also drew a rival offer from Novo Nordisk.
If you are interviewing with a financial institutions group or tackling a banking consolidation case, you can point to the 2025 wave of European banking and insurance takeovers, alongside global payments and asset management deals:
- Swiss insurers Helvetia and Baloise announced a merger, while Deutsche Borse held discussions to acquire the Allfunds platform.
- Italy's UniCredit built a stake in Germany's Commerzbank and signaled interest in an acquisition, while announcing and later withdrawing an intention to acquire domestic peer Banco BPM.
- Italy's Banca Monte dei Paschi di Siena acquired a majority stake in Mediobanca, which subsequently launched an offer to acquire Banca Generali from insurer Generali that was rejected.
- Italy's BPER Banca made a tender offer to take over domestic rival Banca Popolare di Sondrio.
- France's Group BPCE agreed to acquire a majority stake in Portugal's Novo Banco, and French Credit Mutuel Alliance Federale acquired Germany's Oldenburgische Landesbank through its Targobank subsidiary.
- Spain's BBVA launched a takeover offer for Spanish peer Banco de Sabadell that eventually lapsed, while Banco Santander's UK unit agreed to acquire UK-based TSB Banking Group from Banco Sabadell.
- Outside Europe, Global Payments announced the acquisition of Worldpay, and Nomura acquired Macquarie's US and European public asset management business.
Enterprise M&A practice: readiness, carve-outs, and AI due diligence
When you make your final recommendation in an M&A case, do not treat signing the deal as the finish line. Enterprise dealmakers cannot rely on opportunism when regulatory reviews and market volatility stretch timelines. Deals fail more often because of a weak strategy and poor integration than because of price or due diligence issues. Companies with strong megadeal capabilities, including a clear strategic rationale and integration playbooks, outperform peers and reduce downside risk. If your case client is a private equity fund, keep in mind that sponsors face strong pressure to put money to work, holding about $2 trillion in undeployed capital as of December 2025 (following a record $2.1 trillion at the end of September 2024) as global PE deal value rose 59% in 2025 and venture capital funding climbed about 60%.
You can also stand out in interviews by mentioning how technology and generative AI change day-to-day transaction execution. Deal teams use digital search tools for faster target identification, program management software for integration and separation, and virtual data rooms with AI-based contract redaction and information extraction. During due diligence, advanced analytics and machine learning process large volumes of structured and unstructured data to speed up document review and support business planning, financial modeling, and valuation.
Use this six-step enterprise M&A readiness checklist, built by our team from BCG's deal-readiness practices and SEC public filing tools, when you structure a buy-side or sell-side case:
- 1. Define strategy and target-selection criteria: Tie every potential acquisition or joint venture to a specific value creation thesis, whether acquiring for growth, efficiency, technology, or skilled talent in an acquihire.
- 2. Set financial guardrails early: Establish valuation boundaries and synergy requirements before bidding, tracking market multiples such as the S&P 1200 price-to-earnings ratio (which stood at 24.5x in October 2024 versus 15.5x in October 2022).
- 3. Prepackage carve-outs and divestitures: Prepare noncore or overlapping business units for separation ahead of time so you can divest underperforming assets or resolve antitrust overlap quickly.
- 4. Deploy AI in virtual data rooms and diligence: Use AI-based contract redaction, information extraction, and machine learning analytics to review structured and unstructured diligence data faster.
- 5. Check public filings on SEC EDGAR: Use the US Securities and Exchange Commission's free EDGAR system to search more than 20 years of public company filings by keyword, company name, ticker, CIK, or SIC code, including registration statements, periodic reports, and confidential treatment orders.
- 6. Build integration playbooks before signing: Map post-merger integration steps and synergy capture plans during diligence so execution begins the day regulatory approval clears.
Worked example: evaluating an M&A divestiture remedy in a case interview
In consulting and investment banking interviews, M&A cases often test whether a deal still creates value after regulators require a divestiture or condition to approve the transaction. Below is an original worked example created by our team to show the step-by-step math you would do with pen and paper.
Prompt (invented scenario by our team): AcquirerCo wants to buy TargetCo for an enterprise value of $1,200 million. TargetCo generates $150 million in annual standalone EBITDA. AcquirerCo expects $50 million in annual pre-tax cost synergies from combining logistics networks. However, to clear antitrust review in two overlapping regional markets, AcquirerCo must divest a group of TargetCo warehouses that generate $30 million in annual EBITDA. Removing those warehouses also eliminates $10 million of the planned annual cost synergies. A mid-market logistics buyer will pay 8.0x EBITDA for the divested warehouses. AcquirerCo's board requires the net acquisition multiple on retained post-synergy EBITDA to be at or below 6.5x. Should AcquirerCo proceed with the deal?
Work the math in four labeled steps, stating your units out loud before you calculate:
- Step 1. Calculate proceeds from the required divestiture: $30 million divested EBITDA multiplied by the 8.0x divestiture multiple equals $240 million in cash proceeds.
- Step 2. Calculate the net purchase price for the retained business: $1,200 million gross purchase price minus $240 million divestiture proceeds equals $960 million net enterprise value paid.
- Step 3. Calculate retained post-synergy annual EBITDA: Start with $150 million standalone EBITDA, subtract $30 million divested EBITDA to get $120 million retained standalone EBITDA. Add the net remaining synergies of $40 million ($50 million initial synergies minus $10 million lost synergies) to reach $160 million in retained post-synergy annual EBITDA.
- Step 4. Calculate the effective acquisition multiple and compare to the board guardrail: Divide the $960 million net purchase price by $160 million retained post-synergy EBITDA to get 6.0x. Because 6.0x is below the board's 6.5x maximum guardrail, the deal passes the financial test even after the antitrust divestiture.
How consulting firms test M&A and strategy in case interviews
When you interview for a client-facing consulting role at firms like BCG or McKinsey, you solve business problems that mirror real corporate decisions. At BCG, the consulting interview process has four steps: an online Application, a Skills Interview covering your experience and motivation, a Case Interview assessing problem-solving and analytical skills, and a Team Interview. BCG also offers OneDay@BCG, a free job simulation showing the types of challenges consultants solve.
During a BCG case study interview, you work through a realistic business challenge step by step: structure your approach, ask thoughtful questions, analyze data, perform quick calculations, and identify the most important factors. BCG notes that there is not always a single right answer. Interviewers look for clear communication, logical thinking, business intuition, creativity, clarifying assumptions, and showing your thinking without rushing or panicking under pressure.
At McKinsey, candidates for most consulting roles complete the Solve gamified assessment, followed by Personal Experience Interviews (PEI) and Problem-Solving Interviews (case interviews), plus Expertise Interviews for select roles. McKinsey publishes five sample practice cases on its careers page (Beautify, Diconsa, Electro-Light, Transforming a national education system, and Talbot Trucks) and advises candidates to listen carefully and share solutions built for the specific case rather than standard frameworks.
If you use AI while preparing for M&A and strategy interviews, follow the firm's integrity rules. McKinsey encourages candidates to use AI to polish a resume, practice interview questions, and ask AI to explain concepts or frameworks during prep. However, McKinsey strictly prohibits using AI to exaggerate or create achievements, generate real-time answers during an interview, or assist during assessments unless specifically permitted, and requires candidates to disable note-taking or virtual assistant AI software during virtual interviews. You can practice out loud with Soreno's AI interviewer to build your structure and math speed before your real round.
Practice question: pharma acquisition and antitrust review
Use this practice prompt to test how you combine financial guardrails, antitrust remedies, and post-merger integration in a live case opening. Read the prompt, take two minutes to build your structure on paper, and say your answer out loud before comparing it with our team's example answer below.
From BCG: The Early Signs of an M&A Industry Recovery (October 16, 2024), BCG: M&A Outlook 2026: Expectations Are High, Again (January 15, 2026), SEC.gov: EDGAR Search Filings, BCG Careers: Consulting Case Study Interview Preparation, BCG Careers: Consulting Interview Process and McKinsey & Company: Interviewing at McKinsey.
1 practice question and sample answer
Say your answer out loud first, then read the sample answer.
Practice question
Your client is a large US pharmaceutical company planning a $15 billion acquisition of a biotech competitor that develops obesity treatments. Given heightened antitrust scrutiny in pharma and recent bidding competition for targets like Metsera, how would you structure the due diligence and regulatory readiness plan for the CEO?
Sample answer. Example answer written by our team. The applicant is invented. I would structure the CEO's readiness plan across three areas: strategic and financial guardrails, antitrust and carve-out preparation, and integration readiness. First, on financial guardrails, competing bids in pharma can quickly drive up multiples, so I would set a strict walk-away price based on standalone pipeline cash flows plus verified R&D and commercial synergies. Second, because large pharmaceutical deals face heavy antitrust scrutiny, I would audit where our clinical pipelines and commercial drugs overlap with the target. If regulators are likely to challenge a specific therapeutic overlap, we should prepackage a carve-out or licensing divestiture now and identify credible buyers before announcing the deal, or evaluate whether a collaborative joint venture could achieve the same R&D goals with lower regulatory risk. Third, since deals fail more often from weak strategy and poor integration than from price, I would use AI-enabled virtual data rooms to speed up contract extraction during diligence and build a day-one retention plan for the target's key clinical scientists. I would start by sizing the overlapping revenue and pipeline assets.
The answer states a clear three-part structure built for a pharmaceutical transaction, incorporates real enterprise practices (financial guardrails, prepackaging divestitures or joint ventures, and AI diligence tools), and ends by proposing the first analytical step.
Practice the case interview, out loud
Soreno's AI interviewer runs a full case one question at a time, checks your math and scores your structure, any time you have 30 minutes.
Questions people ask
How does antitrust scrutiny affect large enterprise M&A deals?
Traditional antitrust scrutiny complicates larger transactions, creates unpredictability around approval outcomes and timelines, and is of special concern to large technology and pharmaceutical companies. At the same time, antitrust review can promote dealmaking when companies use divestitures and carve-outs to resolve regulatory objections.
What is a recent example of a merger receiving conditional regulatory approval?
In 2024, The Walt Disney Co. and Reliance Industries received conditional regulatory approval in India for an $8.5 billion merger of their Indian media assets into a joint venture. The transaction created India's largest entertainment company while sharing investment and regulatory risk.
What were the largest consolidation megadeals announced in 2025?
There were 39 megadeals above $10 billion announced in 2025, led by Paramount Skydance's $74.3 billion offer for Warner Bros. Discovery (surpassing Netflix's $69.9 billion offer) and Union Pacific's $71.5 billion acquisition of railroad operator Norfolk Southern. Other major deals included a $49.4 billion buyout of Electronic Arts, Kimberly-Clark's $42.8 billion deal for Kenvue, and Alphabet's $32 billion acquisition of Wiz.
Why do enterprise M&A transactions fail most often?
Deals fail more often because of a weak strategy and poor integration than because of price or due diligence issues. Enterprise deal teams reduce this risk by establishing clear target-selection criteria, financial guardrails, and integration playbooks before opportunities arise.
How do enterprise deal teams use AI in M&A due diligence?
Dealmakers use AI and generative AI tools to search for acquisition targets, manage integration programs, and run virtual data rooms with AI-based contract redaction and information extraction. During due diligence, machine learning and advanced analytics process structured and unstructured data to speed up document review and support financial modeling and valuation.
More guides
- Environmental Consulting Interview Questions and Answers
- McKinsey Acceptance Rate: Official Hiring Process & Stages
- Risk Consulting Interview Questions and Answers (2026)
- Consulting Presentation Slides: Structure, Charts & Build
- FTI Consulting Salary: Filings, Benchmarks & Pay (2026)
- Management Consulting Slide Deck: Structure and Guide
- CaseBasix Alternatives for Case Interview Prep (2026)
- Consulting Firm Hierarchy: Ranks at McKinsey, BCG and Bain
- Consulting Strategy Group: Services, Pay, and Vetting
- Deloitte Discovery Intern: How to Apply and Interview
- KPMG Verbal Reasoning Test: Format, Example and Prep
- Marketing and Strategy Consulting Firms Guide (2026)